TD50
The dosage of a drug which is TOXIC in 50% of the population
LD50
The dosage of a drug which is LETHAL in 50% of the population
Therapeutic Window
The range of drug plasma concentrations for which it is effective without causing toxic effects
Bioavailability
Tolerance
When the body becomes less responsive to the effects of the drug, LARGER AND LARGER DOSES are needed for the same effect
Addiction
Where a user develops a physical dependence on a drug
Side Effects
The negative effects of the administration of a drugs
Drug Receptor Interactions
When it comes to IBDP Chemistry, many drugs are designed to target SURFACE RECEPTOR PROTEINS, these drugs can have different effects e.g.
- Agonistic: Drug acts in a similar way to substrate, activating the receptor and the associated response
- Antagonistic: Drug blocks the substrate binding site and prevents the natural substrate from activating the receptor
- Allosteric: Drug binds to a site other than the substrate binding site. This may increase/decrease the receptors response to the natural substrate
Mild Analgesic
A drug which works by intercepting the pain stimulus at the SOURCE, it does this by preventing the synthesis of substances that cause pain.
Strong Analgesic
A drug that work by temporarily bonding to opioid receptors in the BRAIN and present transmission of pain impulses
Compliance
Patient's willingness and ability to take a medication in the correct doses, at the correct times for the whole course prescribed
Opiates
Naturally occuring narcotic compounds from opium poppy (Morphine)
Oploids
Any compound with a similar structure to morphine (Codeine, Heroin)
Solubility
Opiates and Opioids must cross the Brain Blood Barrier to work, the more hydrophobic (non-polar) a compound is, the more rapidly it penetrates the BBB.
High-level Waste
Low-level Waste
Waste which gives off small amounts of ionising radiation for short periods of time, these isotopes will have short half-lives and few nuclei decay each second
Chrial Auxiliary
An optically active substance that is temporarily encorparated into an organic synthesis so that is can be carried out asymmetrically with the formation of a single enantiomer
This is the end of this topic.